EMA guideline on core SmPC, labelling and package leaflet for ATMPs containing genetically modified cells
Last updated: 2 October 2024 See update at the end of the post. The European Medicines Agency (EMA) issued a draft guideline in August for comments, on core Summary of Products Characteristics (SmPC), labelling and package Leaflet for ATMPS containing…